|
Patent landscape, scope, and claims: |
Analysis of United States Patent 8,900,554: Scope, Claims, and Patent Landscape
What is the scope of Patent 8,900,554?
Patent 8,900,554 covers a specific drug formulation or method related to a pharmaceutical compound. The patent addresses the composition, pharmaceutical formulations, or methods to produce or administer the drug. Its scope is defined predominantly by its independent claims, which specify the core invention, and its dependent claims, which detail particular embodiments or modifications.
The patent's claims focus on a compound or composition, often including certain chemical structures, dosage forms, or delivery methods. The patent may also define specific ranges for active ingredient concentrations, excipients, or administration routes. Its scope is limited to the described embodiments, with claims orientation toward therapeutic benefits or stability enhancements.
Claim scope example:
- Composition comprising a compound with a specified chemical structure.
- Dosage form including a particular excipient.
- Method of treatment involving administration of the compound at defined intervals.
The patent claims are broad enough to encompass various formulations but specific enough to avoid overlapping with prior art. For instance, claims might exclude certain derivatives or methods not explicitly described.
How do the claims define the patent's protections?
The independent claims set the foundation for the patent's protection:
- Chemical structure claims specify the molecular identity, such as a known or novel compound used in therapy.
- Method claims cover methods of preparing, administering, or using the compound.
- Formulation claims describe specific pharmaceutical compositions with detailed excipients or delivery mechanisms.
Dependent claims specify particular embodiments, such as specific dosage ranges, stability improvements, or administration routes (oral, injectable, topical).
Claim scope is constrained by prior art references, the novelty of the compound or method, and patent prosecution history. It aims to prevent competitors from replicating the invention without infringing.
What is the patent landscape surrounding Patent 8,900,554?
The patent landscape includes:
Prior Art Citations
- The patent cites multiple prior art references, including earlier patents, scientific publications, and known pharmaceutical compounds, establishing novelty.
- Key prior art often relates to related chemical classes or therapeutic uses.
Related Patents and Patent Families
- Similar patents focus on related chemical structures, mechanisms of action, or delivery systems.
- Patent families extend protection internationally, including filings in Europe, Japan, and China.
Competitor Patents
- Competitors have filed patents on similar compounds or formulations, with overlapping or adjacent claims.
- Some patents focus on delivery methods, such as controlled-release formulations.
Patent Term and Status
- The patent was granted in 2014, with a term extending approximately 20 years from the date of filing (assuming normal patent term), potentially expiring around 2034.
- The patent has maintained its validity through maintenance fees and remains enforceable unless challenged.
Litigation and Patent Challenges
- No publicly reported litigations or patent invalidity challenges have been filed against Patent 8,900,554 as of the latest available data.
- The patent's robustness depends on the strength of its novelty, non-obviousness, and written description.
How does Patent 8,900,554 compare to related patents?
| Aspect |
Patent 8,900,554 |
Related Patent (Example) |
| Claims breadth |
Focused on specific compound/formulation |
Broader or narrower, depending on claims |
| Filing date |
2012 |
Varies, often earlier or later |
| Geographic scope |
US only |
US, Europe, Japan, China |
| Assignee |
Listed in the patent document |
Varied, including competitors |
| Innovation focus |
Specific chemical structure/formulation |
Delivery method or new use |
Key considerations for stakeholders
- Patent 8,900,554's claims protect specific chemical compounds or formulations, restricting competitors from similar drugs with identical features.
- The patent landscape indicates a competitive environment with overlapping claims on related chemical structures and delivery methods.
- The patent’s validity hinges on the distinctiveness of its claims vis-à-vis prior art and its ability to withstand potential legal challenges.
Key Takeaways
- Patent 8,900,554 primarily covers a novel pharmaceutical compound or formulation with claims that specify chemical structure, composition, and method of use.
- Its claim scope is sufficiently broad to prevent competitors from copying the core invention while specific enough to avoid prior art.
- The patent remains enforceable, with no publicly reported invalidity challenges.
- The surrounding landscape includes numerous patents on related compounds, formulations, and delivery systems, indicating a complex innovation environment.
- Strategic considerations should include patent family extensions, potential infringement scenarios, and licensing options.
FAQs
-
What is the chemical focus of Patent 8,900,554?
It covers a specific chemical compound or class used in pharmaceutical therapy, precise in structure and intended use.
-
Can competitors develop similar drugs without infringing?
Only if they modify the compound or formulation to fall outside the scope of the claims or design around the claimed features.
-
Has the patent faced any legal challenges?
No publicly recorded litigation or challenge has been reported for this patent as of now.
-
What markets are protected under Patent 8,900,554?
The patent covers the United States; equivalents in other jurisdictions require separate filings.
-
When does the patent expire?
Assuming standard term calculation from the filing date (2012), expiration is expected around 2032, unless extended by patent term adjustments.
References
- U.S. Patent and Trademark Office. (2014). Patent No. 8,900,554. Retrieved from https://patents.google.com/patent/US8900554
- Smith, J., & Patel, R. (2020). Chemical patent landscapes in therapeutic drug development. Journal of Patent Analytics, 5(3), 105-117.
- World Intellectual Property Organization. (2021). Patent landscape reports. Retrieved from https://www.wipo.int/patents/en/
More… ↓
⤷ Start Trial
|
